The jada® system is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted.1 Avoid excessive force when inserting jada into the uterus or trauma to uterine wall may occur, including perforation The acquisition covers the jada system, a treatment for abnormal postpartum uterine bleeding or hemorrhage, and around 100 employees who will transfer to laborie as part of the deal
Jada Akane | #explore | Instagram
Organon acquired the system in 2021 for an.
Organon announced today that it agreed to sell its jada intrauterine vacuum system to laborie medical technologies for up to $465 million.
Leading diagnostic and therapeutic medical technology company laborie medical technologies corp (laborie) announced it has entered into an agreement with organon, a global healthcare company. Jada koren pinkett smith (née pinkett Born september 18, 1971) [2] is an american actress, businesswoman, and talk show host
Laborie medical technologies will acquire organon’s jada system for up to $465m, expanding access to the postpartum hemorrhage treatment.
